ATE233319T1 - Transfektierte zelllinie, exprimierend dns die für die nmda-r2a rezeptor untereinheit und für isoformen der nmda-r1 untereinheit des menschlichen nmda-rezeptors kodieren - Google Patents

Transfektierte zelllinie, exprimierend dns die für die nmda-r2a rezeptor untereinheit und für isoformen der nmda-r1 untereinheit des menschlichen nmda-rezeptors kodieren

Info

Publication number
ATE233319T1
ATE233319T1 AT93924747T AT93924747T ATE233319T1 AT E233319 T1 ATE233319 T1 AT E233319T1 AT 93924747 T AT93924747 T AT 93924747T AT 93924747 T AT93924747 T AT 93924747T AT E233319 T1 ATE233319 T1 AT E233319T1
Authority
AT
Austria
Prior art keywords
nmda
subunit
receptor
human
cell line
Prior art date
Application number
AT93924747T
Other languages
English (en)
Inventor
Bourdelles Beatrice Le
Janice Ann Myers
Paul John Whiting
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929223769A external-priority patent/GB9223769D0/en
Priority claimed from GB939307026A external-priority patent/GB9307026D0/en
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Application granted granted Critical
Publication of ATE233319T1 publication Critical patent/ATE233319T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT93924747T 1992-11-12 1993-11-11 Transfektierte zelllinie, exprimierend dns die für die nmda-r2a rezeptor untereinheit und für isoformen der nmda-r1 untereinheit des menschlichen nmda-rezeptors kodieren ATE233319T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929223769A GB9223769D0 (en) 1992-11-12 1992-11-12 Receptor cloning
GB939307026A GB9307026D0 (en) 1993-04-02 1993-04-02 Receptor cloning
PCT/GB1993/002324 WO1994011501A1 (en) 1992-11-12 1993-11-11 cDNAs ENCODING HUMAN NMDA-22A RECEPTOR SUBUNIT AND ISOFORMS OF THE HUMAN NMDA-R1 RECEPTOR SUBUNIT, TRANSFECTED CELL LINE EXPRESSING THEM

Publications (1)

Publication Number Publication Date
ATE233319T1 true ATE233319T1 (de) 2003-03-15

Family

ID=26301962

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93924747T ATE233319T1 (de) 1992-11-12 1993-11-11 Transfektierte zelllinie, exprimierend dns die für die nmda-r2a rezeptor untereinheit und für isoformen der nmda-r1 untereinheit des menschlichen nmda-rezeptors kodieren

Country Status (9)

Country Link
US (1) US6130058A (de)
EP (1) EP0672140B1 (de)
JP (1) JPH08503362A (de)
AT (1) ATE233319T1 (de)
AU (1) AU5429794A (de)
CA (1) CA2148599C (de)
DE (1) DE69332715T2 (de)
DK (1) DK0672140T3 (de)
WO (1) WO1994011501A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2110934A1 (en) 1992-12-11 1994-06-12 Robert L. Foldes Human cns receptors of the nmda-r1 family
CA2159106C (en) * 1993-04-20 2009-10-06 Lorrie P. Daggett Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor
EP0674003A3 (de) * 1994-03-25 1997-09-10 Allelix Biopharma Proteine die menschliche CNS Rezeptoren modulieren.
GB9414997D0 (en) * 1994-07-26 1994-09-14 Merck Sharp & Dohme Receptor cloning
US20050037969A1 (en) * 1999-05-14 2005-02-17 Arbor Vita Corporation Molecular interactions in hematopoietic cells
JP4114029B2 (ja) * 1999-07-16 2008-07-09 株式会社セガ 画像処理装置、画像処理方法及び記録媒体
US20050064442A1 (en) * 2002-11-25 2005-03-24 Roth Richard B. Methods for identifying risk of breast cancer and treatments thereof
AU2003293141A1 (en) * 2002-11-25 2004-06-18 Sequenom, Inc. Methods for identifying risk of breast cancer and treatments thereof
US20050272043A1 (en) * 2003-07-24 2005-12-08 Roth Richard B Methods for identifying risk of breast cancer and treatments thereof
EP1766051A4 (de) * 2004-05-27 2007-10-10 Sequenom Inc Verfahren zur identifizierung des brustkrebsrisikos und behandlungen davon
WO2017109709A2 (en) 2015-12-22 2017-06-29 Novartis Ag A high-throughput assay method for identifying allosteric nmda receptor modulators
CN114375396A (zh) * 2019-09-13 2022-04-19 欧蒙医学实验诊断股份公司 改进的nmda受体自身抗体检测

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4216321A1 (de) * 1992-05-16 1993-11-18 Basf Ag Untereinheiten von NMDA-Rezeptoren, Verfahren zu ihrer Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
JPH08503362A (ja) 1996-04-16
EP0672140B1 (de) 2003-02-26
DE69332715T2 (de) 2003-10-16
AU5429794A (en) 1994-06-08
CA2148599C (en) 2004-01-20
CA2148599A1 (en) 1994-05-26
US6130058A (en) 2000-10-10
WO1994011501A1 (en) 1994-05-26
DE69332715D1 (de) 2003-04-03
EP0672140A1 (de) 1995-09-20
DK0672140T3 (da) 2003-03-31

Similar Documents

Publication Publication Date Title
ATE233319T1 (de) Transfektierte zelllinie, exprimierend dns die für die nmda-r2a rezeptor untereinheit und für isoformen der nmda-r1 untereinheit des menschlichen nmda-rezeptors kodieren
DK0687268T3 (da) Spiroazacykliske derivater som substans P-antagonister
EP1017713A4 (de) ZYKLISCHE AGONISTEN UND ANTAGONISTEN DER C5a REZEPTOREN SOWIE G-PROTEIN GEKOPPELTEN REZEPTOREN
YU53899A (sh) Primena inhibitora ciklooksigenaze-2 u prevenciji kardiovaskularnih poremećaja
DK0695301T3 (da) Indolderivater som 5-HT1-lignende agonister til anvendelse ved migræne
MY141384A (en) Prevention of loss and restoration of bone mass by certain prostaglandin agonists
MXPA04004457A (es) Novedosos derivados de 1,2,4-tiadiazolio como moduladores del receptor de melanocortina.
NO945036D0 (no) Vandig materiale som inneholder en organisk peroksysyre
DE69414256T2 (de) Tropyl 7-azaindol-3-ylcarboxamide als antitussivum
MY129189A (en) Prostaglandin agonists and their use to treat bone disorders
TR199700644T1 (xx) Serotonin-ili�kili sistemler �zerinde etkiye sahip bile�ikler.
RS39704A (sr) Novi 1,2,4-tiadiazolijum derivati kao modulatori melanokortinskog receptora
ATE423562T1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
DK0724435T3 (da) Amidinoderivater, der er nyttige som nitrogenoxid-synthase-inhibitorer
ES2067874T3 (es) Derivados de acetamida.
ATE311449T1 (de) Stabil transfizierte zelllinien welche gaba-a- rezeptoren mit der untereinheitenzusammensetzung alpha-3, beta-3 und gamma-2 exprimieren
ATE368664T1 (de) Pteridinon-derivate als modulatoren der chemokinrezeptor-aktivität
NO943133D0 (no) Benzodiazepinderivater egnet til bruk som CCK-reseptorantagonister
GR3022445T3 (en) Process for testing an electronic electricity meter.
DK0555446T3 (da) Anvendelse af antagonister eller partielle agonister ved 5-HT1a-receptoren til behandling og forebyggelse af kognitive fors
DE69328549T2 (de) Für einen humanen serotoninrezeptor (5-ht4b) kodierende dns und ihre verwendung
AU5588094A (en) The pct-65 serotonin receptor
DK1040106T3 (da) Carboxylsubstituerede chromanderivater til anvendelse som beta 3 adrenoreceptor-agonister
ZA852495B (en) Anticonvulsant agents
IL85425A (en) Anticonvulsant compositions containing substituted benzoyl anilides, some such novel compounds and process for their preparation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties